Coil Embolization of Variant Hepatic Arteries During Percutaneous Arterial Port Catheter Placement for Intraarterial Chemotherapy: Analysis of Intrahepatic Perfusion Redistribution and Treatment Efficacy-Reference-Cited by-同舟云学术

Coil Embolization of Variant Hepatic Arteries During Percutaneous Arterial Port Catheter Placement for Intraarterial Chemotherapy: Analysis of Intrahepatic Perfusion Redistribution and Treatment Efficacy

Published:2022-11-01 Issue:1 Volume:46 Page:69-79
ISSN:0174-1551
Container-title:CardioVascular and Interventional Radiology
language:en
Short-container-title:Cardiovasc Intervent Radiol

Author:

Kobe Adrian^ORCID,Deschamps Frédéric,Meyblum Louis,Varin Eloi,Delpla Alexandre,Hakime Antoine,Teriitehau Christophe,Roux Charles,Boileve Alice,Gelli Massimiliano,de Baère Thierry,Tselikas Lambros

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging

Link

https://link.springer.com/content/pdf/10.1007/s00270-022-03303-y.pdf

Reference26 articles.

1. Kwan J, Pua U. Review of intra-arterial therapies for colorectal cancer liver metastasis. Cancers. 2021;13:1371.

2. Zhao JJ, Tan E, Sultana R, Syn NL, Zhuang KD, Leong S, et al. Intra-Arterial therapy for unresectable colorectal liver metastases: a meta-analysis. J Vasc Interv Radiol. 2021;32:1536-1545.e38.

3. Chapelle N, Matysiak-Budnik T, Douane F, Metairie S, Rougier P, Touchefeu Y. Hepatic arterial infusion in the management of colorectal cancer liver metastasis: current and future perspectives. Digest Liver Dis. 2018;50:220–5.

4. Boilève A, Maillard A, Wagner M, Dromain C, Laurent C, Bierre ED, et al. Treatment intensification with hepatic arterial infusion chemotherapy in patients with liver-only colorectal metastases still unresectable after systemic induction chemotherapy: a randomized phase II study–SULTAN UCGI 30/PRODIGE 53 (NCT03164655)-study protocol. BMC Cancer. 2020;20:74.

5. Pernot S, Pellerin O, Mineur L, Monterymard C, Smith D, Lapuyade B, et al. Phase III randomized trial comparing systemic versus intra-arterial oxaliplatin, combined with LV5FU2 +/- irinotecan and a targeted therapy, in the first-line treatment of metastatic colorectal cancer restricted to the liver (OSCAR): PRODIGE 49. Digest Liver Dis. 2022;54:324–30.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Usefulness of tumor perfusion on cone-beam CT after hepatic arterial infusion port implantation for evaluating tumor response to hepatic arterial infusion chemotherapy in hepatocellular carcinoma treatment;Diagnostic and Interventional Radiology;2023-11-01

2. Exploring a Novel Technique to Tackle the Shortage of Devices for Hepatic Arterial Infusion Chemotherapy: Early Results of an Alternate Approach for Percutaneous Arterial Port Catheter Placement;Cancers;2023-09-26